Largest biotech by revenue

Everything the company sold in its latest fiscal year, before any cost is taken off.

Amgen leads the 21 biotech ranked by revenue, at $36.8B, ahead of Gilead Sciences ($29.4B) and Biogen ($9.9B). Figures as of 18 Nov 2026, 12:56 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
21
First
Amgen$36.8B
Median
$1.2B
Combined market value
$849.1B
Countries
5
Not ranked
3no revenue on file

Market values as of .

Largest biotech by revenue
#CompanyRevenue ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health Care$36.8B$247.7B$457.93 0.95% down 34% up United States
2Gilead SciencesGILD · Health Care$29.4B$211.2B$170.26 1.60% up 33% up United States
3BiogenBIIB · Health Care$9.9B$37.1B$250.79 0.34% down 49% up United States
4argenxARGX · Health Care$4.2B$59.6B$947.52 0.36% down 4% up Belgium
5BioNTechBNTX · Health Care$3.2B$21B$84.86 0.47% down 16% down Germany
6Neurocrine BiosciencesNBIX · Health Care$2.9B$16.8B$165.92 0.37% up 20% up United States
7ExelixisEXEL · Health Care$2.3B$16.7B$68.50 2.09% up 63% up United States
8QiagenQGEN · Health Care$2.1B$10.3B$49.75 0.12% down 12% up Netherlands
9ModernaMRNA · Health Care$1.9B$83.7B$206.80 3.93% down 755% up United States
10Halozyme TherapeuticsHALO · Health Care$1.4B$10.9B$95.97 0.55% down 37% up United States
11Bio-TechneTECH · Health Care$1.2B$11.4B$72.63 0.22% down 26% up United States
12RepligenRGEN · Health Care$738.3M$10.4B$162.18 0.37% down 5% up United States
13Krystal BiotechKRYS · Health Care$389.1M$8.8B$298.55 0.22% up 46% up United States
14Twist BioscienceTWST · Health Care$376.6M$7.6B$112.00 6.63% up 340% up United States
15Adaptive BiotechnologiesADPT · Health Care$277M$4.6B$28.49 2.22% up 88% up United States
16ImmunityBioIBRX · Health Care$113.3M$6.7B$6.26 4.68% up 193% up United States
17Kymera TherapeuticsKYMR · Health Care$39.2M$10.4B$121.52 3.44% down 87% up United States
18CG OncologyCGON · Health Care$4M$7.1B$78.94 6.89% down 85% up United States
19CRISPR TherapeuticsCRSP · Health Care$3.5M$3.9B$40.15 0.54% down 21% down Switzerland
20Revolution MedicinesRVMD · Health Care$0$35.2B$162.69 2.50% down 131% up United States
21Scholar Rock HoldingSRRK · Health Care$0$5.5B$45.08 1.21% up 14% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. 3 companies have no revenue on file and are not ranked here.

Questions and answers

Which biotech rank first by revenue?

Amgen ($36.8B), Gilead Sciences ($29.4B) and Biogen ($9.9B) are the top three of the 21 biotech ranked by revenue as of 18 Nov 2026, 12:56 UTC.

How many biotech are in this ranking?

21 are ranked by revenue. 3 more have no revenue on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 21 biotech ranked by revenue have a combined market value of $849.1B as of 18 Nov 2026, 12:56 UTC.

What does ranking by revenue measure?

Everything the company sold in its latest fiscal year, before any cost is taken off.

Cite this page

Funkfolio, “Largest biotech by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=revenue

Underlying data: Yahoo Finance; SEC EDGAR.